Lv1
52 积分 2023-05-29 加入
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
2天前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
2天前
已完结
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
27天前
已完结
Clinical significance of plasma PD-L1(+) exosomes in the management of diffuse large B cell lymphoma
1个月前
已完结
Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma
1个月前
已关闭
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
1个月前
已完结
CAR immune cells: design principles, resistance and the next generation
1个月前
已完结
Daratumumab–lenalidomide and the immunosuppressive budget in myeloma
4个月前
已完结
Myeloid-derived suppressor cells in cancer and cancer therapy
5个月前
已完结
Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy
5个月前
已完结
皖公网安备34019202002308
